Invited Speakers

Invited Speakers

Jeremy Abramson, MD, MMSc
Director, Center for Lymphoma
Massachusetts General Hospital Cancer Center
Assistant Professor of Medicine,
Harvard Medical School
Boston, MA

Ranjana Advani, MD
Saul A. Rosenberg Professor of Lymphoma
Stanford Cancer Institute
Department of Medicine/Oncology
Stanford, CA

Stephen Ansell, MD, PhD
Professor of Medicine
Mayo Clinic College of Medicine
Consultant, Division of Hematology
Chair of Faculty Development and Recruitment, Division of Hematology
Department of Internal Medicine
Rochester, MN

Koen van Besien, MD, PhD
Director of Stem Cell Transplant Program
Professor of Medicine
Weill Cornell Medical College
Attending Physician
New York-Presbyterian Hospital
New York, NY

Elias Campo, MD, PhD
Chief, Hematopathology Unit
Professor of Pathology
Hospital Clinic of Barcelona
University of Barcelona
Barcelona, Spain

Andrew Evens, DO, MSc, FACP
Associate Director for Clinical Services
Rutgers Cancer Institute Medical Director
Oncology Service Line
RWJ Barnabas Health Director, Lymphoma Program
Division of Blood Disorders Professor of Medicine
Rutgers Robert Wood Johnson Medical School
New Brunswick, NJ

Timothy Fenske, MD
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Milwaukee, WI

Christopher Flowers, MD, MS
Director, Lymphoma Program
Professor Hematology and Medical Oncology
Bone Marrow and Stem Cell Transplantation
Winship Cancer Institute
Emory University
Atlanta, GA

Jonathan Friedberg, MD, MMSc
Samuel E. Durand Professor of Medicine
Director, Wilmot Cancer Institute
University of Rochester Medical Center
Rochester, NY

Leo Gordon, MD
Abby and John Friend Professor of Oncology Research
Professor of Medicine (Hematology and Oncology)
Northwestern University
Feinberg School of Medicine
Robert H. Lurie Comprehensive Cancer Center
Chicago, IL

John Gribben, MD, DSc, FMedSci
Chair of Medical Oncology
Barts Cancer Institute – a CR-UK Centre of Excellence
Queen Mary University of London
3rd Flr John Vane Science Centre
Charterhouse Square, London

Steven Horwitz, MD
Associate Professor of Medicine
Joan and Sanford I. Weill Department of Medicine
Weill Cornell Medical College
Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, NY

Justin Kline, MD
Assistant Professor, Department of Medicine
Section of Hematology/Oncology
The University of Chicago Medicine
Chicago, IL

John P Leonard, MD
Interim Chairman, Joan and Sanford I. Weill Department of Medicine
Interim Physician-in-Chief, New York-Presbyterian Hospital/Weill Cornell Medical Center
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Associate Dean for Clinical Research
Associate Director, Sandra and Edward Meyer Cancer Center
Weill Cornell Medicine|New York- Presbyterian
New York, NY

Barbara Pro, MD
Professor of Medicine
Section of Hematology/Oncology
Northwestern University
Feinberg School of Medicine
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, IL

Sonali Smith, MD
Elwood V. Jensen Professor of Medicine
Section of Hematology/Oncology
Director, Lymphoma Program
The University of Chicago
Chicago, IL

Julie Vose, MD, MBA
Neumann M. and Mildred E. Harris Professor
Chief, Division of Hematology/Oncology
Professor of Medicine
University of Nebraska Medical Center
Omaha, NE

William Wierda, MD, PhD
D.B. Lane Cancer Research Distinguished Professor
Department of Leukemia, Division of Cancer Medicine
Executive Medical Director
Professor, Department of Leukemia, Division of Cancer Medicine
Section Chief – Chronic Lymphocytic Leukemia, Department of Leukemia
Division of Cancer Medicine Center
Medical Director, Department of Leukemia, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Faculty Disclosure

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with anycommercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.